Peter Reimnitz

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

Robert Wilson, Tobias Welte, Eva Polverino et al. · European Respiratory Journal · 2012 · 202 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Moxifloxacin vs Ampicillin/Sulbactam in Aspiration Pneumonia and Primary Lung Abscess

Sebastian R. Ott, M. Allewelt, J. Lorenz et al. · Infection · 2008 · 102 citations · Full text

Medicine, Infectious Diseases, Microbiology +16

Treatment with Sequential Intravenous or Oral Moxifloxacin Was Associated with Faster Clinical Improvement than Was Standard Therapy for Hospitalized Patients with Community-Acquired Pneumonia Who Received Initial Parenteral Therapy

Tobias Welte, Wolfgang Petermann, Dirk Schürmann et al. · Clinical Infectious Diseases · 2005 · 90 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Influence of Stroke Localization on Autonomic Activation, Immunodepression, and Post-Stroke Infection

Hendrik Harms, Peter Reimnitz, Georg Böhner et al. · Cerebrovascular Diseases · 2011 · 80 citations · Full text

Life Sciences, Immunology, Neurology +17

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial

Jonathan Ross, H.S. Cronjé, Tomasz Paszkowski et al. · Sexually Transmitted Infections · 2006 · 65 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13